The Optimized Follow-up Protocol for Pediatric Metaphyseal Forearm Fractures

NCT ID: NCT06678568

Last Updated: 2024-11-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-11-05

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The randomized controlled study which compare radiologic outcomes (loss of reduction rate) and complications in pediatric patients with displaced metaphyseal forearm fractures who underwent conservative treatment. The patients were assigned in two different follow-up protocols. In the control group, the patients will go to hospital for follow-up visit and film every week until 4th week after injury. In the intervention group, the patients will go to hospital for follow-up visit every week except in the 3rd week after injury they will be gotten telemedicine follow-up.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Randomization of patients for 2 different follow-up protocols

Objective: to compare loss of reduction rate by angulation measurement and prevalence of complications in patients with displaced metaphyseal forearm fractures who underwent conservative treatment.

Method:

Patients will be randomly assigned to one of two groups using various block computerized randomization. Randomization will be performed using STATA version 16.0, Statacorp, College Station, Texas, USA

Interventions:

Group 1 (control group): The patients will go to hospital for follow-up visit and film every week until 4th week after injury.

Group 2 (intervention group): The patients will go to hospital for follow-up visit every week except in the 3rd week after injury they will be gotten telemedicine follow-up.

Treatment Allocation and concealment:

A randomization will prepare with sealed envelopes containing assigned follow-up protocols for each patient.

The envelopes will be labeled with the study ID.

Blinding:

Because of the two different of follow-up protocol, we cannot blind the protocol from participants, physicians and assessors.

Outcomes:

1. Primary outcome is loss of reduction rate using angulation measurement. The definition of loss of reduction angulation is angulation which is more than 10 degree in coronal view or more than 20 degree in sagittal view. Angulation measurement will be measured in bisector between longitudinal axis and center of diaphysis. Angulation will be measured by two physicians and two times using PACS (Picture Archiving and Communication System) in Ramathibodi hospital.
2. Secondary outcomes are other complications such as malunion, nonunion, joint stiffness and cast problem

Statistical Analysis Plan:

Data will be recorded in Microsoft Excel and imported to STATA version 16.0 for re-check.

For continuous data, use mean and standard deviation (S.D.) For categorical data, use frequency and percentage For comparing non-normal distribution between group, use Mann-Whitney test and for continuous data, use Fisher's exact test Define the Statistical significant is p-value \< 0.05 Data analysis will be performed with STATA version 16.0, Statacorp, College Station, Texas, USA.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wrist Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

The standard follow-up protocol

follow-up and film every week at hospital

Group Type NO_INTERVENTION

No interventions assigned to this group

The optimized follow-up protocol

follow-up and film every week at hospital except the 3rd week is telemedicine follow-up

Group Type EXPERIMENTAL

telemedicine follow-up in 3rd week

Intervention Type OTHER

Intervention group will be appointed with telemedicine follow-up in 3rd week after injury, instead of hospital follow-up visit.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

telemedicine follow-up in 3rd week

Intervention group will be appointed with telemedicine follow-up in 3rd week after injury, instead of hospital follow-up visit.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 0-12 years
* Patients with distal metaphyseal forearm fractures in Ramathibodi hospital and Chakri Naruebodindra Medical Institute
* Presented to hospital within 72 hours of injury

Exclusion Criteria

* Open fracture
* Operative treatment at 1st visit
* Neurovascular injury
* Polytraumatized patient
* Ipsilateral fracture of upper limb
* History of previous surgery in the affected arm
* Metabolic bone disease
Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nonticha Thanthong

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nonticha Thanthong

Sponsor Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Medicine Ramathibodi Hospital, Mahidol University

Ratchathewi, Bangkok, Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nonticha Thanthong, Doctor of medicine

Role: CONTACT

(+66)898829505

Chanika Angsanuntsukh, Diploma of orthopaedics

Role: CONTACT

(+66)917767879

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MURA2024/689

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.